Korsana Biosciences, Inc. Common Stock (KRSA)

• Market cap: $10.1B
• 1 day: -2.65%
• 5 days: 32.72%
• 1 month: 19.2%
• 3 months: 19.2%
• 6 months: 19.2%
• Year to date: 19.2%
• 1 year: 19.2%
• 5 years: 19.2%
• 10 years: 19.2%
• Sector: Healthcare
• Industry: Biotechnology

About: Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibody that combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.